Estimated effectiveness of co-administration of the Pfizer-BioNTech COVID-19 vaccine with influenza vaccine

JAMA Network Open

2023-11-08

(Press-News.org) About The Study: In this study that included 3.4 million adults, co-administration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (Pfizer-BioNTech) and seasonal influenza vaccine was associated with generally similar effectiveness in the community setting against COVID-19–related and seasonal influenza vaccine-related outcomes compared with giving each vaccine alone and may help improve uptake of both vaccines.

Authors: Leah J. McGrath, Ph.D., of Pfizer Inc., in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.42151)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.42151?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110823

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Age at diagnosis of atrial fibrillation and incident dementia

2023-11-08

About The Study: Earlier onset of atrial fibrillation was associated with an elevated risk of subsequent all-cause dementia, Alzheimer disease, and vascular dementia in this study including 433,000 UK Biobank participants, highlighting the importance of monitoring cognitive function among patients with atrial fibrillation, especially those younger than 65 years at diagnosis. Authors: Fanfan Zheng, Ph.D., of the Chinese Academy of Medical Sciences & Peking Union Medical College in Beijing, and Wuxiang Xie, Ph.D., of the Peking University First ...

Physicists trap electrons in a 3D crystal for the first time

2023-11-08

Electrons move through a conducting material like commuters at the height of Manhattan rush hour. The charged particles may jostle and bump against each other, but for the most part they’re unconcerned with other electrons as they hurtle forward, each with their own energy. But when a material’s electrons are trapped together, they can settle into the exact same energy state and start to behave as one. This collective, zombie-like state is what’s known in physics as an electronic “flat band,” and scientists predict that when electrons are in this state they can start to ...

Scaling up nano for sustainable manufacturing

2023-11-08

A new self-assembling nanosheet could radically accelerate the development of functional and sustainable nanomaterials for electronics, energy storage, health and safety, and more. Developed by a team led by Lawrence Berkeley National Laboratory (Berkeley Lab), the new self-assembling nanosheet could significantly extend the shelf life of consumer products. And because the new material is recyclable, it could also enable a sustainable manufacturing approach that keeps single-use packaging and electronics out of landfills. The ...

Validating the role of inhibitory interneurons in memory

2023-11-08

Memory, a fundamental tool for our survival, is closely linked with how we encode, recall, and respond to external stimuli. Over the past decade, extensive research has focused on memory-encoding cells, known as engram cells, and their synaptic connections. Most of this research has centered on excitatory neurons and the neurotransmitter glutamate, emphasizing their interaction between specific brain regions. To expand the understanding of memory, a research team led by KAANG Bong-Kiun (Seoul National University, Institute ...

Scientists tame biological trigger of deadly Huntington’s disease

2023-11-08

Huntington’s disease causes involuntary movements and dementia, has no cure, and is fatal. For the first time, UC Riverside scientists have shown they can slow its progression in flies and worms, opening the door to human treatments. Key to understanding these advancements is the way that genetic information in cells is converted from DNA into RNA, and then into proteins. DNA is composed of chemicals called nucleotides: adenine (A), thymine (T), guanine (G), and cytosine (C). The order of these nucleotides determines what biological instructions are contained in a strand of DNA. On occasion, some DNA nucleotides repeat themselves, ...

Disturbances in sensory neurons may alter transient pain into chronic pain

2023-11-08

Utrecht, November 8, 2023 - Researchers from the Center for Translational Immunology at University Medical Center Utrecht (the Netherlands) have identified that a transient inflammatory pain causes mitochondrial and redox changes in sensory neurons that persist beyond pain resolution. These changes appear to predispose to a failure in resolution of pain caused by a subsequent inflammation. Additionally, targeting the cellular redox balance prevents and treats chronic inflammatory pain in rodents. Pain often persists in patients with an ...

SMU Lyle nanorobotics professor awarded prestigious research grant to make gene therapy safer

2023-11-08

DALLAS (SMU) – SMU nanotechnology expert MinJun Kim and his team have been awarded a $1.8 million, R01 grant from the National Institutes of Health (NIH) for research related to gene therapy – a technique that modifies a person’s genes to treat or cure disease. NIH R01 (Research Program) grants are extremely competitive, with fewer than 10 percent of applicants receiving one. The four-year grant will allow Kim, the Robert C. Womack Chair in the Lyle School of Engineering at SMU (Southern Methodist University) and principal investigator ...

$200M gift propels scientific research in the search for life beyond earth

2023-11-08

$200m Gift Propels Scientific Research in the Search for Life Beyond Earth Legacy of Franklin Antonio represents quantum leap for The SETI Institute November 8, 2023, Mountain View, CA – The SETI Institute, a non-profit scientific research organization, announced today a philanthropic gift of $200m from the estate of Franklin Antonio, a visionary supporter and catalyst of the work of the SETI Institute for more than 12 years. Co-founder of communications chip company, Qualcomm, Antonio passed away on May 13, 2022, leaving behind an extraordinary ...

Blood clotting risk quickly drops after stopping hormonal contraceptives

2023-11-08

(WASHINGTON, Nov. 8, 2023) – Using birth control pills and other hormone-based contraceptives is known to elevate the risk of blood clots about three-fold, but a new study suggests that this risk largely goes away within two to four weeks after one stops using these contraceptives, according to research published today in Blood. The findings – the first to provide such confirmatory guidance on the best timing to stop contraception – can help patients and doctors weigh the benefits and risks of hormonal contraceptives and guide when to stop using them ahead of events that could further increase the risk of dangerous clots, such as major surgery, ...

New study highlights connection with strawberries, cognition and mood in middle-aged, overweight adults

2023-11-08

A new study published in Nutrients shows daily consumption of strawberries for 12 weeks reduced interference in memory and depressive symptoms among middle-aged, overweight adults with self-reported mild cognitive decline. “Dementia is a general term that includes many different diseases, all without remedies,” says Robert Krikorian, Ph.D., principal investigator and professor in the department of psychiatry at the University of Cincinnati Academic Health Center. “It is not clear when ...

Estimated effectiveness of co-administration of the Pfizer-BioNTech COVID-19 vaccine with influenza vaccine

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: